AJR Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Awai, K.
Right arrow Articles by Yamashita, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Awai, K.
Right arrow Articles by Yamashita, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
DOI:10.2214/AJR.04.1591
AJR 2006; 186:379-385
© American Roentgen Ray Society


Original Research

Simulation of Aortic Peak Enhancement on MDCT Using a Contrast Material Flow Phantom: Feasibility Study

Kazuo Awai1, Atsushi Hatcho2, Yoshiharu Nakayama1, Shinichiro Kusunoki1, Duo Liu1, Masahiro Hatemura3, Yoshinori Funama4, Masayuki Denbo5, Natsuko Sato6 and Yasuyuki Yamashita1

1 Department of Diagnostic Radiology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjyo, Kumamoto 860-8556, Japan.
2 Department of Radiology, Nagano Red Cross Hospital, Nagano, Japan.
3 Department of Radiology, Kumamoto University Hospital, Kumamoto, Japan.
4 Department of Radiological Technology, Kumamoto University School of Health Sciences, Kumamoto, Japan.
5 Nemoto-Kyorindo, Tokyo, Japan.
6 Philips Medical Systems, Tokyo, Japan.

OBJECTIVE. The objective of our study was to develop a flow phantom simulating aortic peak enhancement after the injection of contrast material on CT and to investigate the validity of the flow phantom by comparing the time-enhancement curves obtained for the flow phantom and humans.

MATERIALS AND METHODS. We developed a flow phantom simulating the enhancement pattern of the aorta after the injection of contrast material. In protocols 1, 2, and 3 of the phantom study, 90, 102, and 150 mL of iohexol, respectively, was administered over 35 sec. In protocol 4, 102 mL of iohexol was administered over 25 sec. In phantom protocols 1', 2', and 3', the dose and contrast injection duration were the same as in protocols 1, 2, and 3; however, saline (10 mL) was injected during the 20 sec after contrast delivery. In the human study, 20 patients were randomized into four groups: Groups A, B, and C received 1.5, 1.7, and 2.5 mL of iohexol per kilogram of body weight, respectively, over 35 sec; and group D received 1.7 mL/kg over 25 sec. In patient groups A, B, C, and D, phantom protocols 1, 2, 3, and 4 were used, respectively. Single-level serial CT scans were obtained using a 16-MDCT scanner on the simulated and real aortas after the injection of contrast material. Time-enhancement curves of simulated and real aortas were generated, and aortic peak times and aortic peak enhancement values were calculated.

RESULTS. Aortic peak enhancement and aortic peak times in protocols 1-4 and 1'-3' of the phantom study were 2-8% larger and 6-18% longer, respectively, than in the corresponding patient study. The shape of the time-enhancement curves before aortic peak time in protocols 1-3 and 1'-3' of the phantom study closely resembled that of the corresponding patient study. After the aortic peak time, the shape of time-enhancement curves in protocols 1, 2, and 3 of the phantom study was different from the corresponding patient study; however, it was similar in phantom protocols 1'-3' and the corresponding patient study. In all four phantom protocols, the difference between maximal and minimal aortic peak enhancement was less than the SD of the corresponding patient study.

CONCLUSION. The level of peak aortic enhancement and the time to peak aortic enhancement were similar in the phantom and human studies when we used our different contrast injection protocols for MDCT.

Keywords: aorta • contrast media • MDCT • phantom study


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Roentgen Ray Society.